Phase 3 Trial Results with Blisibimod, a Selective Inhibitor of B-Cell Activating Factor, in Subjects with Moderate-to-Severe Systemic Lupus Erythematosus

被引：0
|
作者：
Merrill, Joan T. [1 ]
Martin, Renee S. [2 ]
Shanahan, William [2 ]
Scheinberg, Morton [3 ]
Kalunian, Kenneth C. [4 ]
Wofsy, David [5 ]
机构：
[1] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA
[2] Anthera, Hayward, CA USA
[3] Ctr Clin Immunol, Dept Immunol, Sao Paulo, SP, Brazil
[4] UCSD Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[5] UCSF, Rheumatol, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
888
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHASE 3 TRIAL RESULTS WITH BLISIBIMOD, A SELECTIVE INHIBITOR OF B-CELL ACTIVATING FACTOR, IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Merrill, J.
    Martin, R. S.
    Shanahan, W. R.
    Scheinberg, M.
    Kalunian, K.
    Wofsy, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 864 - 864
  • [2] Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus.
    Furie, Richard A.
    Scheinberg, Morton A.
    Leon, Gustavo
    Ramiterre, Edgar B.
    Thomas, Matthew
    Martin, Renee S.
    Petri, Michelle A.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4169 - 4169
  • [3] Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
    Merrill, Joan T.
    Shanahan, William R.
    Scheinberg, Morton
    Kalunian, Kenneth C.
    Wofsy, David
    Martin, Renee S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) : 883 - 889
  • [4] A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
    Furie, R. A.
    Leon, G.
    Thomas, M.
    Petri, M. A.
    Chu, A. D.
    Hislop, C.
    Martin, R. S.
    Scheinberg, M. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (09) : 1667 - 1675
  • [5] EFFECTS OF BLISIBIMOD, AN INHIBITOR OF B CELL ACTIVATING FACTOR, ON PATIENT REPORTED OUTCOMES AND DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Petri, M.
    Martin, R. S.
    Hislop, C.
    Scheinberg, M. A.
    Furie, R. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 336 - 337
  • [6] Effects of Blisibimod, an Inhibitor of B Cell Activating Factor, on Patient Reported Outcomes and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Petri, Michelle
    Martin, Renee S.
    Hislop, Colin
    Scheinberg, Morton A.
    Furie, Richard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1239 - S1240
  • [7] B-Cell activating Factor Genetic Variants in Systemic Lupus Erythematosus and Lupus Related Atherosclerosis
    Theodorou, Evangelos
    Nezos, Adrianos
    Kostantopoulou, Pinelopi
    Tektonidou, Maria
    Koutsilieris, Michael
    Mavragani, Clio P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
    Furie, Richard
    Morand, Eric
    Bruce, Ian
    Manzi, Susan
    Kalunian, Kenneth
    Vital, Edward
    Lawrence-Ford, Theresa
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip
    Berglind, Anna
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] EFFECTS OF BLISIBIMOD, AN INHIBITOR OF B-CELL ACTIVATING FACTOR, ON MARKERS OF RENAL DISEASE IN PATIENTS WITH SLE
    Furie, R.
    Scheinberg, M.
    Leon, G.
    Ramiterre, E. B.
    Thomas, M.
    Chu, A. D.
    Hislop, C.
    Martin, R. S.
    Petri, M. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 95 - 95
  • [10] Efficacy and Safety of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus: Results of the Second Phase 3 Randomized Controlled Trial
    Morand, Eric
    Furie, Richard
    Tanaka, Yoshiya
    Bruce, Ian
    Askanase, Anca
    Riche'z, Christophe
    Bae, Sang-Cheol
    Brohawn, Philip
    Pineda, Lilia
    Berglind, Anna
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345